Skip to content

Lymphocyte T-Cell Receptor Alpha/Beta Double-Negative Subset, Whole Blood

Published: August 9, 2026Updated: August 16, 2026

A blood test that identifies and measures T lymphocytes lacking both alpha- and beta-chain T-cell receptors, a specialized immune-cell subset.

Quick summary

["This test measures a specialized subset of T cells that may provide information about immune-system development or function."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
101414-1
Short code
Lymphocyte TCR A B dbl neg sub pnl Bld
Synonyms
Lymphocyte TCR A B dbl neg sub pnl Bld
Category
liver
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What is this test?

This test measures a specialized group of T lymphocytes, or T cells, that lack both alpha- and beta-chain T-cell receptors. These cells are often called alpha/beta double-negative T cells and are evaluated using a sample of whole blood.

Why might I need this test?

A clinician may order this test when evaluating unusual lymphocyte findings, symptoms related to immune-system function, or suspected inherited conditions affecting T-cell development. It may also be used to follow certain immune disorders.

How is the test performed?

A blood sample is sent to the laboratory, where the lymphocytes are identified and the double-negative T-cell subset is counted or reported as a proportion of the relevant cells. The laboratory may include this measurement as part of a broader lymphocyte subset panel.

How do I prepare for the test?

This test usually requires no fasting or special preparation. Follow the instructions provided by the ordering clinician or laboratory, particularly if other blood tests are being performed at the same visit.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Results are interpreted along with the total lymphocyte count, other T-cell subsets, the person's symptoms, and medical history. A reduced number or proportion of these cells may occur with impaired thymic or T-cell development, while an increased proportion may be seen in some immune or inflammatory conditions. The finding is not diagnostic by itself and requires clinical interpretation.

Short name

TCR alpha/beta double-negative T cells

Frequently asked questions

What does alpha/beta double-negative mean?
It means that the measured T cells do not show either the alpha or the beta chain of the T-cell receptor. These cells are distinct from the more common alpha/beta T cells.
Does an abnormal result mean I have a specific disease?
No. This result is interpreted with other blood counts, immune-cell measurements, symptoms, and medical history. Additional testing may be needed to determine the cause.
Is this the same as a general lymphocyte count?
No. A general lymphocyte count measures total lymphocytes, while this test focuses on a specific T-cell subset. It may be ordered alongside broader lymphocyte subset testing.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy